Literature DB >> 35916921

PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers.

Shuxian An1, Gang Huang1, Jianjun Liu1, Weijun Wei2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35916921     DOI： 10.1007/s00259-022-05905-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  36 in total

1.  Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

Authors:  Marlon Perera; Nathan Papa; Matthew Roberts; Michael Williams; Cristian Udovicich; Ian Vela; Daniel Christidis; Damien Bolton; Michael S Hofman; Nathan Lawrentschuk; Declan G Murphy
Journal:  Eur Urol       Date:  2019-02-14       Impact factor: 20.096

2.  Impact of 68Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Sangwon Han; Sungmin Woo; Yeon Joo Kim; Chong Hyun Suh
Journal:  Eur Urol       Date:  2018-04-18       Impact factor: 20.096

3.  Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.

Authors:  D J Bacich; J T Pinto; W P Tong; W D Heston
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

4.  68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.

Authors:  Mads Ryø Jochumsen; Lars Christian Gormsen; Gitte Lund Nielsen
Journal:  Clin Nucl Med       Date:  2018-02       Impact factor: 7.794

5.  PSMA Expression in Tumor Neovasculature Endothelial Cells of Follicular Thyroid Adenoma as Identified by Molecular Imaging Using 68Ga-PSMA Ligand PET/CT.

Authors:  Thorsten Derlin; Hans-Heinrich Kreipe; Udo Schumacher; Bisharah Soudah
Journal:  Clin Nucl Med       Date:  2017-03       Impact factor: 7.794

6.  Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.

Authors:  Seval Erhamamci; Nesrin Aslan
Journal:  Clin Nucl Med       Date:  2020-03       Impact factor: 7.794

7.  68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma.

Authors:  Nader Hirmas; Catherine Leyh; Miriam Sraieb; Francesco Barbato; Benedikt M Schaarschmidt; Lale Umutlu; Michael Nader; Heiner Wedemeyer; Justin Ferdinandus; Christoph Rischpler; Ken Herrmann; Pedro Fragoso Costa; Christian M Lange; Manuel Weber; Wolfgang P Fendler
Journal:  J Nucl Med       Date:  2021-01-28       Impact factor: 10.057

8.  [68 Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma.

Authors:  Jolanta Kunikowska; Bartosz Cieślak; Beata Gierej; Waldemar Patkowski; Leszek Kraj; Marcin Kotulski; Krzysztof Zieniewicz; Leszek Królicki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-03       Impact factor: 9.236

9.  68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.

Authors:  Giuseppe Carlucci; Robin Ippisch; Roger Slavik; Ashley Mishoe; Joseph Blecha; Shaojun Zhu
Journal:  J Nucl Med       Date:  2020-12-18       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.